Dec 12, 2025
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving…
Dec 11, 2025
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing…
Nov 12, 2025
BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update
Jun 27, 2025
Med (Cell Press) 2025
Sep 19, 2024
Lancet Respiratory Medicine 2024
Sep 14, 2023
JNCCN 2023
Nov 16, 2025
PP01.45: Phase 3 Study of Plinabulin/Docetaxel vs. Docetaxel in 2L/3L…
Oct 23, 2025
Phase 2 study of pembrolizumab (Pemb) plus plinabulin (Plin) and…
Sep 10, 2025
Immune Activation with Plinabulin Enhances Anti-tumor Response Combining Radiation with…
Sep 11, 2020
09.2020 European Society for Medical Oncology (ESMO) Virtual Congress 2020 Plinabulin is…
Aug 10, 2020
06.30.2020 ISSCR 2020 Virtual A Single IV Dose of Plinabulin…
Aug 09, 2020
06.23.2020 American Association for Cancer Research (AACR) Virtual Annual Meeting…
Aug 08, 2020
05.30.2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program…
Aug 07, 2020
03.20.2020 National Comprehensive CancerNetwork (NCCN) Annual Conference (2020) Plinabulin, a…
Aug 01, 2020
12.09.2019 American Society of Hematology (ASH) Annual Meeting (2019) A…
Jul 14, 2020
11.09.2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting (2019)…
09.28.2019 European Society for Medical Oncology (ESMO) Congress (2019) DUBLIN-3,…
09.28.2019 European Society for Medical Oncology (ESMO) Congress (2019) The…
09.09.2019 International Association for the Study of Lung Cancer (IASLC)…